Evidence map›Paper›PMID 34294087›Full record

ArticleDiagnostic pathology2021

Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report.

Federica Pezzuto, Luigi Vimercati, Francesco Fortarezza, Andrea Marzullo, Antonio Pennella, Domenica Cavone, Alessandra Punzi, Concetta Caporusso, Antonio d'Amati, Teresa Lettini and 1 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Pleural mesothelioma.Nature reviews. Disease primers · 2025
    Review
  4. An Evaluation Into the Robustness of Grading of Pleural Mesothelioma Outside of Specialist Centres.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Federica PezzutoPathology Unit Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, via A. Gabelli 61, 35121, Padova, Italy. federica.pezzuto@unipd.it.ORCID http://orcid.org/0000-0002-8023-3108
Luigi VimercatiDepartment of Interdisciplinary Medicine, Occupational Health Division, University of Bari, 1 Umberto I Sq., 70121, Bari, Italy.
Francesco FortarezzaPathology Unit Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, via A. Gabelli 61, 35121, Padova, Italy.
Andrea MarzulloPathology Unit, Department of Emergency and Organ Transplantation - DETO, University of Bari, 1 Umberto I Sq., 70121, Bari, Italy.
Antonio PennellaPathology Unit, Department of Surgery, University of Foggia, 121 Napoli St, 71122, Foggia, Italy.
Domenica CavoneDepartment of Interdisciplinary Medicine, Occupational Health Division, University of Bari, 1 Umberto I Sq., 70121, Bari, Italy.
Alessandra PunziPathology Unit, IRCCS National Cancer Institute "Giovanni Paolo II", 65 Orazio Flacco St, 70124, Bari, Italy.
Concetta CaporussoPathology Unit, Department of Emergency and Organ Transplantation - DETO, University of Bari, 1 Umberto I Sq., 70121, Bari, Italy.
Antonio d'AmatiPathology Unit, Department of Emergency and Organ Transplantation - DETO, University of Bari, 1 Umberto I Sq., 70121, Bari, Italy.
Teresa LettiniPathology Unit, Department of Emergency and Organ Transplantation - DETO, University of Bari, 1 Umberto I Sq., 70121, Bari, Italy.
Gabriella SerioPathology Unit, Department of Emergency and Organ Transplantation - DETO, University of Bari, 1 Umberto I Sq., 70121, Bari, Italy.
University of Bari Aldo Moro · ITUniversity of Padua · ITIstituto Tumori Bari · ITUniversity of Foggia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDiffuse malignant peritoneal mesothelioma (DMPM) is a rare malignant neoplasm with poor survival that shares some similarities with the best-known pleural variant, pleural mesothelioma. The recent European Reference Network on Rare Adult Cancers (EURACAN)/International Association for the Study of Lung Cancer (IASLC) proposals attempted to improve the histological diagnosis and patient risk stratification. Herein, we investigated whether the pathology recommendations and suggestions of the pleural proposals were applicable to diffuse malignant peritoneal mesothelioma.

methodsFifty multiple laparoscopic biopsies of DMPM were consecutively collected at the Pathology Unit of the University of Bari. A two-tier system, i.e., low, and high grade, was used to categorize 34 epithelioid DMPMs. Architectural patterns, cytological features and stromal changes were also reported. Immunohistochemistry was performed for BRCA1-associated protein 1 (BAP1), programmed death-ligand 1 (PD-L1), and Ki67, while fluorescence in situ hybridization (FISH) was performed for p16/cyclin-dependent kinase inhibitor 2A (CDKN2A).

resultsHigh-grade epithelioid mesothelioma, high Ki67, and p16/CDKN2A deletion were significantly associated with short survival (p = 0.004, p < 0.0001, and p = 0.002, respectively). BAP1 loss and PD-L1 negativity were the most common findings. Multivariate analysis revealed that the nuclear grading system and p16 deletion significantly correlated with survival (p = 0.003 each).

conclusionsThe present study examined the prognostic significance of several factors proposed for pleural mesothelioma in an extra pleural site. Notably, the introduction of a grading system may provide better risk stratification in epithelioid DMPM. Ki67, BAP1 and p16/CDKN2A should also be measured whenever possible. A detailed report with all supportive data would allow us to collect sufficient information for use in further studies on larger case series.

Indexed as

AdultAgedAged, 80 and overB7-H1 AntigenBiomarkers, TumorHumansLung NeoplasmsMesotheliomaMesothelioma, MalignantMiddle AgedPeritoneal NeoplasmsPleural NeoplasmsPrognosisB7-H1 AntigenBiomarkers, TumorCD274 protein, humanGradingHistologyPeritoneal mesotheliomaPleural mesothelioma

Identifiers

PMID34294087
PMCPMC8296535
OpenAlexW3183357786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.